Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 5/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26206458 | 0.87 | TMPRSS2 (0.43) | TMPRSS2RIPK1 | |
| SCHEMBL24606306 | 0.84 | TMPRSS2 (0.41) | TMPRSS2RIPK1PIK3CD | |
| SCHEMBL26328814 | 0.83 | TMPRSS2 (0.31) | TMPRSS2RIPK1 | |
| SCHEMBL26328735 | 0.80 | TMPRSS2 (0.35) | TMPRSS2 | |
| SCHEMBL24791772 | 0.79 | POLRMT (0.37) | TMPRSS2PIK3CD | |
| SCHEMBL26206193 | 0.78 | TMPRSS2 (0.48) | TMPRSS2RIPK1 | |
| SCHEMBL26206455 | 0.77 | TMPRSS2 (0.46) | TMPRSS2RIPK1 | |
| SCHEMBL24789693 | 0.77 | POLRMT (0.38) | TMPRSS2PIK3CD | |
| SCHEMBL10153929 | 0.77 | TMPRSS2 (0.44) | TMPRSS2PIK3CD | |
| SCHEMBL23034569 | 0.76 | TMPRSS2 (0.36) | TMPRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780844-B2 | Compounds and methods for treatment of viral infections | GILEAD SCIENCES, INC. (US) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11780844-B2 | Compounds and methods for treatment of viral infections | HAVCR2, EIF2AK2, OAT | TMPRSS2 112/4885RIPK1 4055/4885SLC6A2 2851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.